Medisplint
Medisplint
Intramedullary (IM) nail systems have revolutionized the treatment of long bone fractures, serving as the "gold standard" for femoral, tibial, and humeral diaphyseal injuries. Historically, the transition from the simple Kuntscher nail to modern multi-locking, anatomically contoured titanium systems reflects a deep understanding of biomechanics and biological healing. As a leading manufacturer, we recognize that the current market demands more than just hardware; it requires a synergy of Information Gain—where clinical data meets precision engineering.
In the modern era, "Custom OEM" is no longer just about branding. It is about anatomic harmony. Global healthcare providers are shifting toward personalized implants that accommodate diverse patient demographics, varying bone densities, and complex fracture patterns. This whitepaper explores how Medisplint Orthopedic Instruments Co., Ltd. addresses these macro challenges through advanced metallurgy and disruptive manufacturing processes.
Integration of 3D-modeling and CNC precision allows for nails that mimic the natural elasticity of human bone, reducing the "stress shielding" effect common in legacy stainless steel implants.
Our R&D focuses on distal locking accuracy and minimally invasive insertion techniques, significantly reducing surgical time and radiation exposure for medical staff.
Procurement officers are moving away from single-product vendors toward "System Partners" who offer comprehensive instrument sets alongside the implants to ensure surgical seamlessness.
Founded in 2016, Medisplint Orthopedic Instruments Co., Ltd. is a professional manufacturer specializing in orthopedic implants, fixation systems, and surgical instruments for trauma, spine, and joint reconstruction.
Production Facility
Supply Partners
Quality Inspectors
New Products Annually
The facility supports integrated production, assembly, and quality control operations. With an annual export revenue of around USD 12 million, Medisplint leverages 10 years of industry experience to serve markets in Europe, Southeast Asia, the Middle East, and South America. Our operations are governed by ISO 13485 certification and CE compliance, ensuring every nail and screw meets the most rigorous safety standards.
Transparency in production is the cornerstone of our "Reliability" (E-E-A-T) principle.
Our 2025 roadmap includes the development of carbon-fiber reinforced PEEK nails for radiolucent properties and expandable nail technologies that adapt to canal morphology without reaming.
We provide full documentation support for localized registrations (FDA 510k, CE MDR). Our team assists distributors in navigating complex regulatory barriers to ensure rapid market entry.
From private labeling to modifying the proximal bend of a femoral nail, our 85 engineering specialists transform clinical feedback into tangible orthopedic solutions.
Large-scale hospital groups and international distributors often face a "service gap" where high-cost brands lack flexibility, and low-cost manufacturers lack quality. Medisplint bridges this via Vertical Integration. By controlling everything from raw material inspection (as seen in our testing labs) to the final laser marking, we offer 30% faster lead times compared to traditional tier-1 brands.
Our testing suite includes Fatigue Testers, Tensile Testers, and Two-Dimensional Measuring Instruments. This ensures that a Medisplint nail can withstand the cyclical loading of a walking patient during the 12-16 week healing phase without deformation.
